Page last updated: 2024-09-04

cyc 202 and phosphonoacetic acid

cyc 202 has been researched along with phosphonoacetic acid in 4 studies

Compound Research Comparison

Studies
(cyc 202)
Trials
(cyc 202)
Recent Studies (post-2010)
(cyc 202)
Studies
(phosphonoacetic acid)
Trials
(phosphonoacetic acid)
Recent Studies (post-2010) (phosphonoacetic acid)
97973931,3587075

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Rosenberg, A; Schaffer, PA; Schang, LM1
Chiocca, EA; Deckter, LA; Kasai, K; Saeki, Y; Yamamoto, S1

Other Studies

4 other study(ies) available for cyc 202 and phosphonoacetic acid

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins.
    Journal of virology, 2000, Volume: 74, Issue:5

    Topics: Animals; Chlorocebus aethiops; Cyclin-Dependent Kinases; DNA, Viral; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Viral; Immediate-Early Proteins; Mutation; Phosphonoacetic Acid; Purines; RNA, Messenger; RNA, Viral; Roscovitine; Simplexvirus; Temperature; Transcription, Genetic; Vero Cells; Virus Replication

2000
Imaging immediate-early and strict-late promoter activity during oncolytic herpes simplex virus type 1 infection and replication in tumors.
    Gene therapy, 2006, Volume: 13, Issue:24

    Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Gene Expression; Genetic Engineering; Genetic Therapy; Genetic Vectors; Herpes Simplex; Herpesvirus 1, Human; Humans; Luciferases; Luminescent Proteins; Mice; Mice, Nude; Models, Animal; Neoplasms, Experimental; Neuroglia; Oncolytic Virotherapy; Phosphonoacetic Acid; Promoter Regions, Genetic; Purines; Roscovitine; Vero Cells; Virus Replication

2006